ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 200,23
-1,29%
Dow Jones
42 342,24
0,04%
DAX
19 710,65
-1,44%
Brent Oil
71,845
-0,75%
Bitcoin
94 325,00
-3,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Mainz BioMed NV (MYNZ) Cours

Mainz BioMed NV

Mainz BioMed NV (MYNZ)

NASDAQ
4,77
0,99
(26,19%)
Fermé 20 Décembre 10:00PM
Retardé de 15 minutes
5,02
0,25
( 5,24% )
Avant marché: 11:39AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
5,02
Prix Achat
4,80
Prix Vente
5,51
Volume échangé
776
0,00 Fourchette du Jour 0,00
3,65 Plage de 52 semaines 53,60
Cap du marché
10,04M
Clôture Veille
4,77
Ouverture
-
Dernière Transaction
1
@
5.44
Dernière heure de transaction
11:39:52
Volume financier
-
VWAP
-
Volume moyen (3 m)
3 215 679
Actions en circulation
2 000 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-
Chiffre d'affairess
895k
Bénéfice net
-26,3M

À propos de Mainz BioMed NV

Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results. Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.

Secteur
Testing Laboratories
Industrie
Testing Laboratories
Site Web
www.mainzbiomed.com
Siège social
Amsterdam, North Holland, Nld
Fondé
-
Mainz BioMed NV est coté dans le secteur Testing Laboratories de la NASDAQ avec le ticker MYNZ. Le dernier cours de clôture d'Mainz BioMed NV était de US$4,77. Au cours de la dernière année, les actions de Mainz BioMed NV ont été négociées dans une fourchette de prix de US$ 3,65 à US$ 53,60.

Mainz BioMed NV compte actuellement 2 000 000 actions en circulation. La capitalisation boursière d'Mainz BioMed NV est de US$9,54 million.

MYNZ Dernières nouvelles

Plus de nouvelles

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

BERKELEY, Calif. and MAINZ, Germany, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in...

il y a 22 heures
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

16 Décembre 2024
Edgar (US Regulatory)

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering

BERKELEY, Calif. and MAINZ, Germany, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in...

16 Décembre 2024
GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]

16 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

13 Décembre 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

13 Décembre 2024
Edgar (US Regulatory)

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules

BERKELEY, Calif. and MAINZ, Germany, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in...

13 Décembre 2024
GlobeNewswire Inc.

Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN

December 11, 2024 -- InvestorsHub NewsWire -- via PESG Research -- The field of precision oncology has witnessed groundbreaking advancements in recent years, and Silexion Therapeutics (NASDAQ:...

11 Décembre 2024
InvestorsHub NewsWire

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

11 Décembre 2024
Edgar (US Regulatory)

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

09 Décembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.020.455.933.651627274.7418238CS
4-3.376-40.20962363038.39610.5563.6517603478.58856624CS
12-3.956-44.0730837798.97616.043.65321567910.35054429CS
26-17.78-77.982456140422.823.23.65237382811.85537434CS
52-39.78-88.794642857144.853.63.65127614813.13150444CS
156-349.78-98.5851183766354.812003.6551191984.21293613CS
260-568.98-99.125435540157412003.6550663993.16969895CS

MYNZ - Frequently Asked Questions (FAQ)

What is the current Mainz BioMed NV share price?
The current share price of Mainz BioMed NV is US$ 5,02
How many Mainz BioMed NV shares are in issue?
Mainz BioMed NV has 2 000 000 shares in issue
What is the market cap of Mainz BioMed NV?
The market capitalisation of Mainz BioMed NV is USD 9,54M
What is the 1 year trading range for Mainz BioMed NV share price?
Mainz BioMed NV has traded in the range of US$ 3,65 to US$ 53,60 during the past year
What is the reporting currency for Mainz BioMed NV?
Mainz BioMed NV reports financial results in USD
What is the latest annual turnover for Mainz BioMed NV?
The latest annual turnover of Mainz BioMed NV is USD 895k
What is the latest annual profit for Mainz BioMed NV?
The latest annual profit of Mainz BioMed NV is USD -26,3M
What is the registered address of Mainz BioMed NV?
The registered address for Mainz BioMed NV is KEIZERSGRACHT 391A, AMSTERDAM, NORTH HOLLAND
What is the Mainz BioMed NV website address?
The website address for Mainz BioMed NV is www.mainzbiomed.com
Which industry sector does Mainz BioMed NV operate in?
Mainz BioMed NV operates in the TESTING LABORATORIES sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NVNINVNI Group Ltd
US$ 6,00
(124,72%)
2,71M
APTOAptose Biosciences Inc
US$ 0,3306
(94,24%)
24,15M
PBMPsyence Biomedical Ltd
US$ 4,56
(85,37%)
9,28M
LATGUChenghe Acquisition I Company
US$ 18,94
(56,01%)
131
AADIAadi Bioscience Inc
US$ 3,17
(36,64%)
982,57k
MTEMMolecular Templates Inc
US$ 0,18
(-48,57%)
282,25k
PRFXPainReform Ltd
US$ 7,08
(-36,56%)
108,89k
CPIXCumberland Pharmaceutical Inc
US$ 1,64
(-29,31%)
144
CARACara Therapeutics Inc
US$ 0,2915
(-28,71%)
202,33k
XHGXChange TED Inc
US$ 0,9451
(-27,30%)
76,14k
APTOAptose Biosciences Inc
US$ 0,3306
(94,24%)
24,15M
PBMPsyence Biomedical Ltd
US$ 4,56
(85,37%)
9,28M
OCEAOcean Biomedical Inc
US$ 0,6161
(4,60%)
6,44M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 29,99
(-8,57%)
6,33M
ADTXAditxt Inc
US$ 0,1916
(-15,22%)
5,62M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
MYNZ
Mainz BioMed NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés